Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case
Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), 2025, onmt_A17
Publication date: Oct 05, 2025
ABSTRACT
---
KEYWORDS
---
CITATION (Vancouver)
Temir NK, Kemaykin VM, Vildanova RF, Kuttymuratov AM, Sergazina TR, Zholdasova SA, et al. Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1):onmt_A17.
APA
Temir, N. K., Kemaykin, V. M., Vildanova, R. F., Kuttymuratov, A. M., Sergazina, T. R., Zholdasova, S. A., Dairova, N. B., & Iskakova, Z. A. (2025). Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A17.
Harvard
Temir, N. K., Kemaykin, V. M., Vildanova, R. F., Kuttymuratov, A. M., Sergazina, T. R., Zholdasova, S. A., . . . Iskakova, Z. A. (2025). Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case. Oncology, Nuclear Medicine and Transplantology, 1(Suppl. 1), onmt_A17.
AMA
Temir NK, Kemaykin VM, Vildanova RF, et al. Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case. Oncology, Nuclear Medicine and Transplantology. 2025;1(Suppl. 1), onmt_A17.
Chicago
Temir, N. K., V. M. Kemaykin, R. F. Vildanova, A. M. Kuttymuratov, T. R. Sergazina, Sh. A. Zholdasova, N. B. Dairova, and Zh. A. Iskakova. "Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case". Oncology, Nuclear Medicine and Transplantology 2025 1 no. Suppl. 1 (2025): onmt_A17.
MLA
Temir, N. K. et al. "Coexistence of Multiple Myeloma and T-Cell Lymphoblastic Leukemia/Lymphoma (Etp-All): A Rare Clinical Case". Oncology, Nuclear Medicine and Transplantology, vol. 1, no. Suppl. 1, 2025, onmt_A17.
REFERENCES
---
LICENSE

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.